Vor Biopharma
NASDAQ: VORCambridge, US · Founded 2015 · 3 known investors
Founders & leadership
NJ
Nathan JorgensenExecutive
AM
Amy MendelExecutive
RA
Robert AngExecutive
Board
KP
Kush ParmarBoard director
JR
Joshua ResnickBoard director
SL
Sven LundbergBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$110.1M disclosed across 1 round · 2020
▶$110.1MraisedJul 2020 · 33 investors · OtherRule 506(b)
▶$110.1MraisedJul 2020 · 33 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nathan JorgensenExecutive Officer
- Amy MendelExecutive Officer
- Kush ParmarDirector
- Joshua ResnickDirector
- Sven LundbergDirector
- Robert AngExecutive Officer, Director
- Offering amount
- $110.1M
- Amount sold
- $110.1M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Vor Biopharma went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Vor Biopharma's investors?
- Vor Biopharma's investors include 5AM Ventures, OUP (Osage University Partners), RA Capital.
- How much funding has Vor Biopharma raised?
- Vor Biopharma has disclosed $110.1M raised across 1 round.
- Where is Vor Biopharma headquartered?
- Vor Biopharma is headquartered in Cambridge, US.